Le contenu

« All Events

GMP 37th Symposium: Pioneering Advances in Pharmacokinetics

October 15 8:00 am - October 17 2:00 pm

€50.00 – €850.00

Dear members,
On behalf of the GMP Board and Scientific Committee, it is our great pleasure to share with you the program of the 37h GMP Symposium.

We hope to see you there with the exciting scientific and social programs.

This symposium fees are as follow (actualized price appears on the left hand-side when you are logged in, membership fees not included):

  • Satellite sessions: free (members only)
  • Gala dinner: 50 euros
  • Symposium:
    • Early Bird (up to July, 31st 2025):
      • Student members WITH poster: 50 euros (Gala dinner included, see abstract guidelines for contacts and application before getting your tickets)
      • Student members WITHOUT poster: 375 euros
      • Academic members: 375 euros
      • Industrial members: 750 euros
    • Standard (after July, 31st 2025):
      • Student members WITH poster: 50 euros (Gala dinner included, see abstract guidelines for contacts and application before getting your tickets)
      • Student members WITHOUT poster: 425 euros
      • Academic members:425 euros
      • Industrial members: 850 euros

Warm regards,

The GMP Board

 

 

37th GMP SYMPOSIUM
PRELIMINARY PROGRAM

Day 1 – 15th Oct 2025

09.30 – 12:30

Workshops (free for members, needs to be booked separately, first come-first served basis):

GMP Satellite session 1: Coming soon

GMP satellite session 2: Coming soon

 

12.30 – 13:30

Arrival and Registration
Welcome Coffee/Tea

13:30 – 13:40

Welcome to 2024 GMP Symposium

 

Session 1

Replacing and refining in vivo pharmacokinetic experiments

Chairs: C. Amara (Sanofi), F. Gattacceca (COMPO, CRCM, Aix-Marseille university)

This session will explore strategies to replace living animals with virtual equivalents, with more human-relevant in-vitro methods, but also to develop innovative bioanalycal techniques to increase the sensitivity of quantification of protein drugs in plasma and tissues.

1- M. Dupré (Sanofi): Pushing the Boundaries of Bioanalysis: Innovative LC-MS Methods for Ultrasensitive Tissue Quantification of Fusion Proteins in Preclinical Studies

2- Loic Laplanche (AbbVie): Transforming Safety Testing: Virtual Control Groups for Ethical and Efficient Research – the VICT3R Project

 

Session 2

New modalities of drug administration 

Chairs: S. Klieber (Sanofi), L. Laplanche (Abbvie), C. Troisi (EsQlabs)

Join us to learn more about how to overcome PK challenge of new modalities ((e.g., LNP, radiopharmaceuticals, PROTACs) and how these innovations collectively aim to improve patient outcomes and expand the therapeutic landscape.

1- Zhizhou Fang (Merck KGA): Optimization Strategy for PROTAC PK/PD with tailored in vitro tools

2- Stephane Guerif (Sanofi): LNP preclinical in vivo imaging for Biodistribution studies

3- Quyen Nguyen (Novartis): Drug Development of Radio pharmaceuticals: specificities and challenges. Illustration with a case study

 

Coffee Break and Poster Session

 

Session 3

New biomarkers for translational studies 

Chairs: E. Chatelut (Oncopole-Toulouse University), N. Perdaems (Syneos Health), A. Martinez (Toulouse university)

Biomarkers and PK are complementary to understand mechanism of action and adverse effects of biologics. Moreover, use of biomarkers dynamics and PK could significantly reduce the large delay between treatment onset and response. The relation between early biomarker dynamics and anticancer drug PK can be used to individualize anticancer treatment.

1- Audrey Delmas (Laboratoires Servier): Translational inputs on the first-in-human study of PRS-344/S095012, a PD-L1x4-1BB antibody-Anticalin fusion protein (Mabcalin) : integration of PK, ADA, BMK and molecular imaging to understand adverse events

2- Nielka Van Erp (Radboud University Medical Center): The use of biomarkers to guide oncolytic treatment decisions

 

Students Poster Blitz

Chairs: Coming soon

We welcome student abstracts in the field of pharmacology (ADME, PK, PD, PBPK,  DDI). All submitted abstracts will be reviewed by the selection committee and chosen  to be part of a poster presentation and short-oral presentation. A “Best Student  presentation” awards will be announced during the GMP Congress 2025. 

The program is open to all students at the Undergraduate, Masters, and Doctoral levels. Presenters must be present during the congress.

Poster Session & Cocktail

 

Day 2 – 16th Oct 2025

8.00 – 8.30

Welcome Coffee/Tea

 

Key Note Speaker: P. Moingeon (Paris-Saclay University)

Intelligent drugs: how AI is transforming healthcare

Chair: C. Amara, M. Coimbra (Sanofi)

Coffee Break and Poster Session

 

Session 4

Artificial Intelligence and Machine Learning shaping the Future of Drug Development

Chairs: O. Nicolas (Sanofi), F. Gattacceca (COMPO, CRCM, Aix-Marseille university), M. Coimbra (Sanofi)

This session is intended to provide insights on how Artificial Intelligence (AI) and Machine Learning (ML) are revolutionizing the pharmaceutical industry. PhD students and industrial experts will present some latest advancements and practical applications in AI-driven drug discovery & development shaping the future of healthcare

1 – Melanie Karlsen (Sanofi): PopPK covariate modeling: can machine/deep learning help?

2- Nicolas Canouï (Aqemia): Drug Discovery Platform at Aqemia: From Molecules to Medicines: Leveraging Physics-informed Generative AI for rational drug design

3- Mohamed Boussena (COMPO, CRCM, Aix-Marseille university): What to do with missing values?

GMP Assemblée Générale

Lunch & Posters

 

Session 5

Beyond a Covariate: Towards Sex-Based Drug Development for Women

Chairs: F. Gallais (Pharmetheus), A. Puszkiel (Cochin University Hospital), C. Troisi (ESQlabs), M. Le Merdy (Simulations Plus)

This session explores the critical need to move beyond treating sex as a simple covariate in drug development for women. We will discuss the differences in drug response between sexes, the considerations for drug use during pregnancy and lactation, and the importance of studying sex differences to create more effective and safer medications for women.

1 – Emma Hansson (Pharmetheus): Regulatory Aspects of Sex-Related Differences in Drug Development: Past, Present and Future

2- Julia Delahousse (Institut Gustave Roussy): Sex differences in pharmacokinetics of anticancer drugs

3- Pieter Annaert (KU Leuven): Predicting pharmacokinetics in perinatal populations

Coffee Break and Poster Session

 

Session 6

Innovations in Drug Transporters                                                                                                     

Chairs: M. De Sousa Mendes (Certara), O. Nicolas (Sanofi)

Discover the latest advancements in drug transport in this captivating session. We will explore how albumin-mediated drug uptake via organic anion transporters is a reality, and its implications for predicting active renal secretion clearance. Additionally, we will examine the crucial role of pre-incubation in these processes and discuss current and future regulatory perspectives. Join us for an in-depth and interactive discussion on these innovations that could support pharmacokinetic predictions and improve drug developments

1 – Sibylle Neuhoff (Certara): Advancing Transporter-Mediated DDI Prediction: From Qualification to Future Applications

2- Peter Tatrai (Solvo): Improving the clinical relevance of in vitro transporter inhibition studies

3- Dan Scotcher (University of Manchester): “Albumin-Mediated drug uptake”

 

One Step Aside

Médicament et philosophie

Chairs: E. Chatelut (Oncopole-Toulouse University), I. Deprez (Certara)
In this presentation, we will explore the current and potential roles of AI in drug R&D and how it redefines the way scientists integrate data generation with technological applications and wet-lab validation. We will deep-dive into the scientific implications, impacts on researchers, and the research process itself. A key question we will address is whether AI represents merely another tool or signifies a more profound shift in scientific inquiry.  

1- Nicolas Martin (former pharmacy intern and journalist at France Culture)

Gala Dinner (please do not forget to get your additional ticket tickets)

 

Day 3 – 17th Oct 2024

8.30 – 9.00

Welcome Coffee/Tea

Session 7

Dose individualization

Chairs: Chatelut (Oncopole-Toulouse University), A. Puszkiel (Cochin University Hospital), M. Le Merdy (Simulations Plus)

Dose individualization will be addressed in several populations, for different drugs, objectives and circumstances: adults vs. children, small molecules vs. biologics, therapeutic vs. financial issues, pre- vs. post-registration.

1 – Frantz Foissac (University of Paris Cité): Getting the Dose Right: Pediatric Specificities

2- Dirk Jan Moes (University of Leiden): Model informed precision dosing of monoclonal antibodies in (hemato)oncology, opportunities and future perspectives

3- Florian Lemaitre (University of Rennes): The curious absence of therapeutic drug monitoring in phase III trials

  

Coffee Break

 

Session 8

Central nervous system and therapy

Chairs: S. Lobet (Calvagone), N. Perdaems (Syneos Health), C. Troisi (ESQlabs)

This session explores innovative strategies to overcome the challenges of delivering therapeutics to the central nervous system (CNS). Topics include Brain shuttle™, a cutting-edge platform enabling the transport of large-molecule drugs across the blood-brain barrier with clinical PK/PD considerations, and BEPO®, a long-acting injectable technology designed for sustained treatment of CNS disorders.

1 – Adolfo Lopez Noriega (Medincell): BEPO®, a clinical drug delivery technology for the treatment of CNS diseases – Long acting injectable

2- Niels Janssen (Roche): Brainshuttle™ – a versatile platform for the delivery of large molecule therapeutics to the CNS. PK/PD tactics towards clinical validation (incl. Trontinemab)

3- Jean-Manuel Pean (Vect-Horus): Enhancing the biopharmaceutical performance of modern drug modalities for CNS disorders with Vectrans® drug targeting technology

Poster Awards

Closing Remarks

Farewell Lunch

Hotel Reservation

13 r Val de Marne, 94250 Gentilly

1 r Sthrau, 75013 Paris

19, place des Vins de France, 75012 PARIS, France 

23 r Lyon, 75012 Paris

12 Avenue de la Porte d’Italie, 75013 PARIS, France 

98 Av. d’Italie, 75013 Paris

22 r Voltaire, 94270 le Kremlin Bicêtre

1-7 Cour du Minervois 75012 PARIS

2 pl Louis Armand, 75012 Paris

8 Rue Van Gogh, 75012 Paris, France

Details

Start:
October 15 8:00 am
End:
October 17 2:00 pm
Cost:
€50.00 – €850.00

Venue

Le Corum
80 avenue Raspail
Gentilly, 94250 France

Tickets

The numbers below include tickets for this event already in your cart. Clicking "Get Tickets" will allow you to edit any existing attendee information as well as change ticket quantities.
37th Gala Dinner
€ 50.00
61 available
37th GMP Symposium Standard
Access to the 37th Symposium presentations, posters and networking excluding Gala dinner
€ 850.00
61 available
Quantity: 0
Total: € 0.00
Log in to purchase
Event Oct 15 - Oct 17 2025